QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 专题：西安交通大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Chinese Lupus Treatment and Research group (CSTAR) registry: X. family history in relation to lupus clinical and immunological manifestations 期刊论文 Clinical and Experimental Rheumatology, 2018, 卷号: 36, 页码: 81-87 作者:  Leng, Xiaomei;  Li, Mengtao;  Li, Xiangpei;  Zhang, Xiao;  Liu, Shengyun 收藏  |  浏览/下载：106/0  |  提交时间：2019/11/19 CSTAR  Family history  Lupus  Phenotypes   Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study. 期刊论文 Clinical and experimental rheumatology, 2018 作者:  Bi Liqi;  Li Yuhui;  He Lan;  Xu Huji;  Jiang Zhenyu 收藏  |  浏览/下载：21/0  |  提交时间：2019/11/19 Rapid Onset of Response Observed with Certolizumab Pegol in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Efficacy and Safety Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study 期刊论文 ARTHRITIS & RHEUMATOLOGY, 2017, 卷号: 69 作者:  Bi, Liqi;  Li, Yuhui;  He, Lan;  Xu, Huji;  Gu, Jieruo 收藏  |  浏览/下载：4/0  |  提交时间：2019/11/26 The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study 期刊论文 CLINICAL RHEUMATOLOGY, 2017, 卷号: 36, 页码: 35-43 作者:  An, Yuan;  Liu, Tian;  He, Dongyi;  Wu, Lijun;  Li, Juan 收藏  |  浏览/下载：2/0  |  提交时间：2019/11/26 Rheumatoid arthritis  China  Therapy  Duration  Biological  DMARD